Literature DB >> 19416196

Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.

Steven W Sutton1, Jonathan Shelton, Craig Smith, John Williams, Sujin Yun, Timothy Motley, Chester Kuei, Pascal Bonaventure, Andrew Gundlach, Changlu Liu, Timothy Lovenberg.   

Abstract

Neuroanatomical studies have shown relaxin-3 neurons, primarily found in the rodent nucleus incertus (NI), project widely into a large number of areas expressing the relaxin-3 receptor (RXFP3), and these data suggest relaxin-3/RXFP3 signaling modulates sensory, emotional, and neuroendocrine processing. The similar distribution of this receptor-ligand pair in the rat, mouse, and monkey brain suggests that experimental findings obtained in lower species will translate to higher species. A role for relaxin-3 and RXFP3 in modulating stress responses is strongly suggested by the expression of corticotropin-releasing factor R1 (CRF-R1) by NI cells, increased relaxin-3 expression in the NI after stress or CRF injection, and hormonal responses to intracerebroventricular (i.c.v.) relaxin-3 injection. Recent data are consistent with a further role for this ligand-receptor pair in modulating memory. In addition, relaxin-3 has been reported to modulate feeding and body weight control. Acute or chronic central (i.c.v. or intraparaventricular) injections of relaxin-3 have shown a consistent stimulatory effect on food consumption while relaxin was inactive, suggesting the phagic effect of relaxin-3 is mediated by RXFP3. We have confirmed the role of RXFP3 in modulating feeding and body weight by using a selective RXFP3 agonist (R3/I5) and antagonist [R3(Delta23-27)R/I5], collecting feeding, body weight, hormone, and body composition data. In addition, we have preliminary body weight and magnetic resonance imaging data from relaxin-3 knockout mice, which on a 129S5:B6 background are smaller and leaner than congenic controls. These data suggest relaxin-3, acting through RXFP3, is involved in coordinating stress, learning and memory, and feeding responses as predicted on the basis of neuroanatomy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416196     DOI: 10.1111/j.1749-6632.2008.03812.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Exercise and diet affect quantitative trait loci for body weight and composition traits in an advanced intercross population of mice.

Authors:  Larry J Leamy; Scott A Kelly; Kunjie Hua; Daniel Pomp
Journal:  Physiol Genomics       Date:  2012-10-09       Impact factor: 3.107

Review 2.  Sex-specific effects of relaxin-3 on food intake and body weight gain.

Authors:  Juliane Calvez; Camila de Ávila; Elena Timofeeva
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

Review 3.  Modulation of forebrain function by nucleus incertus and relaxin-3/RXFP3 signaling.

Authors:  Francisco E Olucha-Bordonau; Héctor Albert-Gascó; Francisco Ros-Bernal; Valeria Rytova; Emma K E Ong-Pålsson; Sherie Ma; Ana M Sánchez-Pérez; Andrew L Gundlach
Journal:  CNS Neurosci Ther       Date:  2018-05-02       Impact factor: 5.243

Review 4.  Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.

Authors:  Sherie Ma; Craig M Smith; Anna Blasiak; Andrew L Gundlach
Journal:  Br J Pharmacol       Date:  2016-12-04       Impact factor: 8.739

Review 5.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 6.  Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.

Authors:  C K Boughton; K G Murphy
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Silencing relaxin-3 in nucleus incertus of adult rodents: a viral vector-based approach to investigate neuropeptide function.

Authors:  Gabrielle E Callander; Sherie Ma; Despina E Ganella; Verena C Wimmer; Andrew L Gundlach; Walter G Thomas; Ross A D Bathgate
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

8.  Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Keizo Takao; Kazunori Nishi; Yasuaki Ito; Yoshitaka Yasuhara; Yasuhito Nakatomi; Chihiro Yokoyama; Kenji Fukui; Tsuyoshi Miyakawa; Masaki Tanaka
Journal:  Front Behav Neurosci       Date:  2011-08-17       Impact factor: 3.558

9.  Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats.

Authors:  Camila de Ávila; Sandrine Chometton; Sherie Ma; Lola Torz Pedersen; Elena Timofeeva; Carlo Cifani; Andrew L Gundlach
Journal:  Psychopharmacology (Berl)       Date:  2020-01-03       Impact factor: 4.530

10.  Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.

Authors:  Jasinda H Lee; Shu Qing Koh; Simone Guadagna; Paul T Francis; Margaret M Esiri; Christopher P Chen; Peter T-H Wong; Gavin S Dawe; Mitchell K P Lai
Journal:  Psychopharmacology (Berl)       Date:  2015-11-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.